Analysts estimate that bluebird bio will report an earnings per share (EPS) of $-0.37. Anticipation surrounds bluebird bio's announcement, with investors hoping to hear about both surpassing estimates ...
EPS represents profitability pershare by dividing net income ... A company can boost its EPS by increasing its earnings or reducing its share count through share buybacks, but a company ...
CORE EARNINGS PER SHARE: One of the Anglo-Swedish pharmaceutical major's preferred metrics, core EPS is expected to come in at $2.04 in the third quarter, according to a company-compiled consensus ...